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Sm_y To provide a basis for the evaluation of screning programmes in Dnmark, a
study was undertaken of the regioal dierces i breast car i e and mortality. AJI 16 regions wer
followed for the 20 year period, 1970-89, before the start of the first population-based p b e
programme m the Copenhagen ty in 1991. Multiplicative Poisson models wer used for
the analysis. In general, the icideK icrsed during this period from 55 to 70 [pr 100,000 standardised
world andard pulation (WSP)l and the analysis shows this to be most pronounced among won below
age 60. The mortaity was more stabl, changing only from 24 to 28 (per 100,000 standardised WSP), but a
signifiant icse ed in the late 198(6k lhe study showd regional diffes in both i and
mortality of brast cancer in Dnmark Both the inidence and the mortaity aried between the regions, with
maximum differe:ees of22%. The analyss showed no variaton m the tim trends in the different regios, and
thus te that the use of a regional comprison group would be a valid basas for evaluation of the
protgamm. Our study, however, the inheret in the evaluation of screenIng
progres without internal control groups-
The first population-based mammographic screening pro-
gramme started in the municipality of Copenhagen in April,
1991. All women in the municipality aged 50-69 years are
invited every second year to a screenig mammography. The
programme comprses approximately 44,000 women, which is
8.3% of the total female population in this age group in
Denmark. In 1993-94, at least three more of the 16 regions
will start screening programmes.
The purpose of the screening is to detect and treat breast
cancer cases earlier, and thus to achieve benefits for the
patients through less radical treatment and prolonged life, as
well as a reduction in effort and costs in the health care
system (de Koning et al., 1992). It is difficult to obtain an
unbiased estimate of the prolonged life of the individual
patient, and breast cancer mortality is therefore used as the
most important measure ofbenefit for the patients. Day et al.
(1989) emphasise the need to monitor the outcome of pro-
grammes to ensure that the aims of the programme are
actually achieved.
The screening programme in Copenhagen is offered to all
women aged 50-69 years, and no internal comparison group
is thus available. One ofthe possibilites in this situation is to
use regions without screening programmes as the control
group. For such an evaluation to be valid it is necessary to
assume that any changes in the breast cancer mortality would
have been similar in the screening and the non-scrning
regions, provided no screening was introduced. The present
study attempts to check this assumption by using data col-
lected in the Danish population and diease resters. The
paper desibes the breast cancer incidence and mortality in
Denmark during the 20 year period, 1970-89, before the first
screening programme was started, and it discusses the possi-
bility of using a regional comparison group for evalating
the potential reduction in breast cancer mortality. Data from
before 1970 were disregarded as they were not considered
relevant for evaluation of the screening activity in the
1990s.
Materal an mt
Data
Data on incident breast cancer cases from 1970-89 were
retrieved from the files of the Danish Cancer Registry (Storm
Corrpondence E. Lynge.
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et al., 1992). A total of49,174 cases were identified from the
ICD-7 codes 170. The data were tabulated by 5 year age
groups (0-4, 5-9, ..., 85 +) 5 year calendar periods
(1970-74, 1975-79, 1980-84, 1985-89) and the 16 regions
(Copenhagen municipality, Frederiksberg municipality and
14 counties) (see Figure 1).
Data on breast cancer deaths during 1970-89 were re-
trieved from the files of the Causes of Death Registry at the
Danish Institute for Clincal Epidemiology (National Board
of Health, 1990). In total, 22,891 deaths were identified from
Fugwe 1 D)enmark divided mto countis. 1, Copenhagen munic-
pality-, 2, Fredelsberg municipality (not marked, geogaphially
surrounded by the Copenhagen municipality); 3, Copenhag 4,
Frederiksborg; 5, Rosklld; 6, Vestsjlland; 7, Storrm; 8, Born-
holm; 9, Fyn; 10, Sondeujyand; 11, Ribe; 12, Vejle; 13,
Ringkobing 14, Ahus; 15, Viborg and 16, Nordjylland coun-
ties
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the ICD-8 code 174 with breast cancer as the underlying
cause ofdeath. The deaths were tabulated in the same way as
the incident cases. Table I shows the incident cases and
deaths by age group and period.
Data on the female population during the period 1970-89
were retrieved from the files of the National Bureau of
Statistics (Danmarks Statistik, 1990). These data were used
to calculate the number of years lived at risk.
Analysis
The study of the geographical differences in incidence and
mortality was separated into two analyses using equivalent
multiplicative Poisson models (Breslow & Day, 1987,
pp. 119-176). It is assumed that for any group specified by
the variables age, time and county, the number of cases
would be a random variable, independent of the others, and
Poisson distributed with mean A,,,n, 1, represents the rate
(incidence or mortality) and nO, represents the number of
years lived at risk in the group specified by age =a,
region = r and time = t. Given the short observation period,
birth cohorts were not considered in the analysis. In both
analyses the age groups 0-29 and 85 + were excluded, leav-
ing 46,320 incident cases and 20,675 deaths, and the analyses
are consequently based on 704 (= four time periods x 16
regions x 11 age groups) incidence rates and 704 mortality
rates.
The analysis was repeated covering only the age group
50-69 years. These analyses thus cover 21,585 incident cases
and 10,026 deaths, and are based on 256 (= four time
periods x 16 regions x four age groups) rates.
The most complex statistical model we have studied
includes all the main effects and all the two-factor interac-
tions, i.e. in log-linear representation:
log i1, = A + Ga+ , + E, + E + G, + E,
or, expressed in another way:
age*region + age*time + region*time,
where age*region represents both of the main effects and the
first-order interaction.
In the analysis likelihood ratio tests are used. All the tests
are successive tests, in which only one interaction or main
effect is excluded at a time. Since most of the tests have a
large number ofdegrees of freedom, a traditional test level of
5% would be too conservative (i.e. all tests would be
significant). Instead, the individual P-values are discussed at
the relevant points in the text. Genstat 5 (Payne et al., 1987)
was used to fit the models.
Table I Total number of breast cancer cases and breast cancer
deaths in Denmark 1970-89 tabulated by age and calendar
period
Period
Age group 1970- 74 1975- 79 1980-84 1985-89
0-4 0/0 0/0 0/0 0/0
5-9 0/0 0/0 0/0 0/0
10-14 0/0 0/0 1/1 0/0
15-19 1/0 0/0 1V1 0/0
20-24 9/2 8/5 411 8/1
25-29 51/12 67/18 61/7 41/7
30-34 131/51 205/57 212/49 196/40
35-39 326/107 453/82 537/115 603/112
40-44 655/190 737/207 902/191 1,228/266
45-49 1,094/355 1,123/314 1,209/289 1,421/383
50-54 1,122/514 1,270/495 1,238/477 1,356/504
55-59 1,1391638 1,340/603 1,417/607 1,432/638
60-64 1,2641656 1,354/709 1,424/648 1,585/724
65-69 1,175/638 1,494/667 1,420/705 1,555/803
70-74 1,101/654 1,353/690 1,524/841 1,553/769
75-79 910/551 1,188/614 1,261/724 1,334/819
80-84 695/406 884/495 872/595 1,028/683
85 + 453/315 6511460 718/618 780/768
Total 10,126/5,089 12,127/5.416 12,801/5,869 14,120/6,517
Results
Incidence
Table H summarises the analysis of the multiplicative Poisson
models covering the age group 30-84 years. In the incidence
model the interactions between region and time (region*time)
and age and region (age*region) can be excluded, as the
P-values are of the order of 0.02. However, the interaction
between age and time (age*time) and the main effect of
region cannot be excluded, as both P-values are below
0.0005. Thus the incidence data can be described by the
model:
log 1g,, =- L + aE + E + t + C,
The age*time effect is shown in Figure 2, in which the
incidence in the period 1970-74 is equal to 1 in each age
group. The incidence in younger women (age 30-59) in-
creases steadily, reaching almost 40% dunng the study
period. lthis is combined with a smaller increase of 10-30%
in incidence in elderly women (age 60-79), turning to a
decrease of about 10% in the oldest age group (age 80-84).
Using the Copenhagen municipality as the standard, the
geographical variation varies from 17% below the standard
in Viborg county to 6% above the standard in Frederisks-
borg county (Table III).
When the analysis was restricted to the age group 50-69
years, all the two-factor interactions could be excluded and
the incidence data for this age group could consequently be
described by the model:
log 1, = IL+ ax + GE, + Mt
The geographical pattern is similar to that found for the age
group 30-84 years. Using the Copenhagen municipality as
Tablk H Breast cancer incidence and mortality in Denmark
1970-89 analysed by age, calendar period and region using multipli-
cative Poisson models
(a) Model fit
Dev
Model d.f Incidence Mortality
A a*r + a*t + r*t 450 465 427
Bi a*r + a*t 495 531 498
B2 a*r + r*t 480 576 473
B3 a*t + r*t 600 654 619
Cl a*r + t 525 646 544
C2 a*t+ r 645 720 689
C3 r*t+ a 630 763 665
Dl a*r 528 911 569
D2 a*t 660 1,021 790
D3 r*t 640 15,762 12,953
D4 a+r+ t 675 833 735
El a + r 678 1,098 760
E2 a+t 690 1,133 836
E3 r + t 685 15,858 13,031
Fl a 693 1,394 859
F2 r 688 16,125 13,064
F3 t 700 16,397 13,495
G constant 703 16,628 13,517
(b) Tests
Test Effect df Dev P
Incidence test
A against BI r*t 45 66 0.021
BI against C2 a*r 150 189 0.017
C2 against D4 a*t 30 113 <0.0005
C2 against D2 r 15 301 <0.0005
Mortality test
A against B2 a*t 30 46 0.030
B2 against C3 a*r 150 192 0.012
C3 against D4 r*t 45 70 0.010
D4 against E3 a 10 12,296 <0.0005
D4 against E2 r 15 101 <0.0005
D4 against El t 3 25 <0.0005
d.f, degrees of freedom; Dev, deviance.BREAST CANCER TRENDS IN DENMARK 135
the standard, the geographical variation varies from 22%
below the standard in Viborg country to 7% above the
standard in Frederiksborg county (data not shown).
Mortality
For the mortality data it seems reasonable to exclude all
three interactions, as the P-values are of the order of
0.01-0.03. However, the main effects age, time and region
cannot be excluded as these P-values are all below 0.0005
(Table II). The mortality data can therefore be described by
the model:
log 1,, = A + aC. + O,+ (XI
The main effects can be described as follows: mortality in-
creases with increasing age, and overall has increased with
time by 8%, the significant change occurring between the two
last periods (Figure 3). Finally, still using the Copenhagen
municipality as the standard, there is a variation in mortality
from 20% below the standard in Sonderjylland county to 3%
above in Frederiksberg municipality (Table III).
When the analysis was restricted to the age group 50-69
years, the interaction between age and region showed a P-
value of 0.005, and the mortality data in this age group can
consequently best be described by the following model:
log A,, = AL+ a, + a,+ a,+ M,
1.5 -
0 :
C
0
0.5-
Again, the geographical pattern is similar to that found for
the age group 30-84 years. Using the Copenhagen
municipality as the standard, there is a variation in the
mortality from 22% below the standard in Sonderjylland
county to 6% above the standard in Frederiksberg munici-
pality (data not shown).
Denmark has the advantage of having reliable population
and disease registers. Population data by sex, age and
municipality are published annually based on the status in
the Central Population Register by 1 January (Danmarks
Statstik, 1990). Mortality data are also published annually
based on death registrations in the Central Population
Register and on death certificates. A high validity has been
found for the breast cancer diagnoses on death certificates
(Storm, 1984). Cancer incidence data are also published
annually based on notifications from clinical departments
and certain speialists, and from autopsy reports. The
notifications are supplemented by cancer diagnoses known
from death certificates, and since 1987 also by cancer diag-
noses recorded in hospital discharge registers. Comparison of
older series of clinically collected records with the cancer
register records has proved the cancer register to be virtually
complete (Hohm et al., 1982; Storm, 1988).
The age-standardised breast cancer incidence was stable in
Denmark up until 1960, but a steady increase has been
observed over the last 30 years (Ewertz & Carstensen, 1988)
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Fngwe 2 Relative breast cancer incidence. Development over
tm for different age groups. Fitted the model log
y+ a+C +Ct+Cj,. (1970-74=1). *, 1970-74; +,
1975-79; *, 1980-84; 1985-89.
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Fugwe 3 Trends of breast cancer mortality with confidence
interval. Fitted in the model: log A= +ca,+nF+a,
(1970-74= 1).
Table m Regional differences in breast cancer incidence and mortality in Denmark 1970-89
Mean population
in 1980
County Incidence CI n Mortality CI aged 30-84
Copenhagen municipality 1 1 170,700
Frederiksberg municipality 0.99 (0.93; 1.05) 1.03 (0.95; 1.12) 33,890
Copenhagen 1.04 (1.00; 1.08) 0.93 (0.88; 0.98) 186,074
Frederiksborg 1.06 (1.01; 1.11) 0.97 (0.91; 1.04) 90,260
Roskilde 0.91 (0.86; 0.96) 0.97 (0.89; 1.05) 54,685
Vestsjzlland 0.84 (0.81; 0.89) 0.84 (0.78; 0.90) 78,374
Storstrsm 0.84 (0.80; 0.88) 0.88 (0.82; 0.94) 76,887
Bornholm 0.86 (0.77; 0.94) 0.84 (0.73; 0.98) 13,780
Fyn 0.94 (0.91; 0.98) 0.85 (0.80; 0.90) 131,289
Sonderjyland 0.88 (0.84; 0.92) 0.80 (0.74; 0.86) 69,723
Ribe 0.84 (0.79; 0.89) 0.86 (0.79; 0.93) 56,508
Vejle 0.91 (0.87; 0.96) 0.93 (0.87; 0.99) 91,585
Ringk0bing 0.88 (0.83; 0.92) 0.90 (0.83; 0.96) 68,281
Arhus 0.91 (0.88; 0.95) 0.88 (0.83; 0.93) 158,376
Viborg 0.83 (0.79; 0.87) 0.86 (0.80; 0.93) 63,774
Nordjylland 0.85 (0.81; 0.88) 0.84 (0.79; 0.89) 135,153
Model used to fit incidence: hg ,1 = + cz. + , + a + cx.. Model used to fit monality: log,,,=A + a + , +O.
(Copenhagen munipality = 1).
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(see Figure 4). The present study shows that the contribution
to this increase in the age-standardised rate comes from all
age groups below 80 years, although the contribution
decreases with increasing age (see Figure 2). The age-stan-
dardised breast cancer mortality was, however, stable up
until the late 1980s. A major increase in the incidence is
expected to be followed by an increase in the mortality unless
an essential improvement in treatment is achieved or a large
proportion of the extra incident cases are non-fatal.
Systematic trials of adjuvant systemic treatment of breast
cancers have been conducted on a national basis in Denmark
since 1977. These trials have shown a reduction in the overall
mortality in premenopausal women after 8-9 years of
follow-up of 20% after treatment with cyclophosphamide
and of 30% with cyclophosphamide + methotrexate + 5-
fluorouracil (CMF). A reduction of 16% has been found in
post-menopausal women below the age of 70 treated with
tamoxifen (Fischerman & Mouridsen, 1988).
No systematic attempt to achieve early diagnosis of breast
cancer has been made in Denmark prior to the Copenhagen
screening programme in 1991. The increase in use of diagnos-
tic mammography, from 37,000 consultations in 1983 to
51,000 consultations in 1990 (National Board of Health,
1989, and H. Carlsen personal communications, 1992), has
been moderate compared with the increase in many other
places. The average tumour diameter has, however, decreased
from 2.73cm in 1983 to 2.51 cm in 1992 (K.W. Andersen,
personal observation, 1993). It is nevertheless surprising that
the breast cancer mortality remained stable for the first 25
years after the incidence started to increase.
Regional differences are present in both the incidence of
and mortality from breast cancer in Denmark, the rates being
highest in urban areas (Carstensen & Jensen, 1986). Further-
more, this study shows that these regional differences have
remained fairly stable over the last 20 years, thus it seems
reasonable to exclude the interaction between region and
time from the models. Ongoing diagnostic mammography
seems to be evenly distnrbuted across counties. In 1990, more
than 80% of the diagnostic mammograms were taken in
women aged 30-69 years. The number of mammograms
taken in Copenhagen, Arhus and Nordjylland was, respec-
tively, equivalent to 5%, 4% and 4% of the number of
women in this age group. As the mammography clinics in
Copenhagen to some extent also recruit women living outside
the municipality, these data indicate an even distribution
across counties (A.H. Andreasen et al., unpublished
data).
The effect of a population-based mammographic screening
programme must be evaluated from the difference between
the observed mortality from breast cancer and the expected
mortality predicted under the assumption that screemng was
not implemented. This prediction must be based on the
mortality in a comparison group, and Day et al. (1989) listed
three possibilities: a historical companrson group, a geo-
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Figwe 4 Breast cancer incidence (0) 1943-89 and mortality
(-) 1943-90 in Denmark age standardised by WSP.
graphical comparison group and a comparison between
screened and unscreened women.
The use of a historical comparison group, i.e. breast cancer
mortality in Copenhagen in the prescreening period, seems
problematic as it is based on the assumption either that the
time can be eliminated or that the time trend can be
modelled. Breast cancer mortality changed considerably
immediately before the start of the Copenhagen screening
programme (see Figure 2) and the time trend would therefore
be difficult to model.
About 70% of the invited women participated in the first
round of the Copenhagen screening programme (K.P.
Olesen, personal observation, 1993), but a comparison
between the screened and unscreened women could be
affected by a severe selection bias, as the screened group will
probably include the most health-conscious and presumably
most healthy women, as seen in the Malm0 study (Gullberg
et al., 1991).
It is possible that a nationwide screening programme will
start in Denmark at some time in the future, but it is not
likely to happen before the crucial 7-10 years after the start
of the Copenhagen screening programme in 1991. It will
therefore be possible during this period to identify a com-
parison group from an area where screening has not been
offered.
A geographical comparison group has been used in two
previous studies. In the Breast Cancer Detection and
Demonstration Project (BCDDP) (Morrison et al., 1988), the
expected mortality for the screened group was calculated
based on the age-specific incidence and case fatality rates
found in the ten regions included in the surveillance,
epidemiology and end results (SEER) data of Young et al.
(1981). In the UK Trial on Early Detection of Breast Cancer
(UK Trial EDBC, 1988), the expected number of breast
cancer deaths in the screening regions was calculated based
on the mortality rates in neighbouring regions. To correct for
geographical differences not due to screening, the expected
number of deaths in the screening regions was furthermore
multiplied by the standardised mortality ratio (SMR) for the
neighbouring regions in the 7 years preceding the start of
screening.
In the BCDDP study it was thus assumed that the
screened population, apart from the screening, was com-
parable with the population in the SEER regions. A similar
assumption would not be reasonable for Denmark, as our
analysis showed that the regional effect could not be
eliminated from the model. By multiplying by the SMR for
the prescreening period in the UK trial, it was assumed only
that the breast cancer mortality trends were similar in the
screening and neighbouring regions. As we found it
reasonable to exclude the interaction between region and
time from our model, the results of our analysis indicate that
a similar assumption would be reasonable for Denmark.
If the Copenhagen screening programme is as efficient as
the Swedish randomised trials (Nystr6m et al., 1993) we
would for the relevant subpopulation expect a 29% reduction
in the breast cancer mortality in Copenhagen compared with
the non-screening regions. The accepted model shows that we
can estimate the expected breast cancer mortality in the
Copenhagen municipality during the next 10 years based on
the observed breast cancer mortality in the other regions
during this period, e.g. Copenhagen = 1/0.88 x Arhus. The
expected breast cancer mortality in Copenhagen is thus 1.14
times the observed breast cancer mortality in Arhus, with a
95% confidence interval of 1.08-1.20. If we assume that the
relevant subpopulation in the Copenhagen municipality has a
29% decreased breast cancer mortality, then the observed
relative breast cancer mortality in Copenhagen will be
0.71 x 1.14 = 0.81, which is well below the lower limit of the
95% confidence interval. The long-term evaluation will of
course be supplemented by short-term end points, as sug-
gested by, for example, Day et al. (1989).
In our analysis, the interaction between region and time is
the crucial term for the validity of using the regional com-
parison group in the evaluation of the Copenhagen screeningBREAST CANCER TRENDS IN DENMARK 137
Table IV Regional differnces in trends of breast cancer mortality in Denmark
1970-89
Period
Region 1970-74 1975-79 1980-84 1985-89
Copenhagen municipality 1 0.94 1.10 1.18
Frederiksberg municipality 1 1.02 0.98 1.13
Copenhagen 1 0.95 0.98 1.03
Frederiksborg 1 1.00 1.03 1.22
Roskilde 1 0.87 1.02 0.99
Vestsjzlland 1 1.00 0.79 0.99
Storstr0m 1 0.98 0.97 1.07
Bornholm 1 1.28 1.32 1.00
Fyn 1 1.02 0.96 1.05
Sonderjylland 1 0.95 1.06 1.14
Ribe 1 0.81 0.76 0.72
Vejle 1 1.05 1.10 1.03
Ringk0bing 1 1.16 0.98 1.25
Arhus 1 1.10 1.14 1.12
Viborg 1 1.09 1.02 1.09
Nordjylland 1 0.86 0.97 1.00
Model used to fit mortality: logkAot = + z + , + a + . (1970-74 = 1).
programme. The P-value for exclusion of this term was 0.010
in the mortality analysis, and we therefore found it
reasonable, with this type of data, to exclude the term from
the final model. The tests used in the present analysis were,
however, somewhat crude and not able to identify whether
any of the 16 regions differed from the rest. If the analysis is
made with the interaction term included, the resulting esti-
mates indicate that the breast cancer mortality in Copen-
hagen municipality has in fact increased slightly more over
the past 20 years than the breast cancer mortality in most
other regions (see Table IV). Furthermore, studies on breast
cancer survival rates indicate that recent improvements in
survival have occurred primarily outside the greater Copen-
hagen area (A.H. Andreasen et al., unpublished data).
The present study indicates that the use of a geographical
comparison group would be a valid basis for evaluation of
the outcome of the screening programme in the Copenhagen
municipality. The benefit of a screening programme is how-
ever frail, as the potentially avoided breast cancer deaths
constitute only a minor part of the total (Anonymous, 1993).
The methodological reservations listed above further
emphasise the need to be cautious. Our study thus underlines
the difficulties inherent in the evaluation of the outcome of
screening programmes without internal control groups.
This study was financially supported by the ECs 'Europe against
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Abbreviaom WSP, world standard population; ICD, International
Classification of Diseases TEDBC, UK Trial of Early Detection of
Breast Cancer, BCDDP, Breast Cancer Detection Demonstration
Project; SEER, Surveillance, Epidemiology, and End Results; SMR,
Standardis Mortality Ratio; d.f., degree of freedom; Dev,
devance.
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